Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
Avelumab（抗PD-L1）作为一线转换维持治疗或二线治疗晚期胃癌或胃食管交界处癌患者的疗效：JAVELIN实体瘤试验的1b期结果
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0508-1
Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B; Xiong, Huiling; Hong, Janet; Chand, Vikram; Safran, Howard
